Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

Double-staining Kit Streamlines Immunofluorescence Workflow

Products are for professional/laboratory use only.

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces the VectaFluor™ Duet kit, offering convenient, ready-to-use immunofluorescence double labeling.

This kit is ideal for use on a wide range of frozen and FFPE tissue samples, combining primary and secondary antibodies to significantly streamline workflow. VectaFluor Duet includes a secondary reagent to detect mouse and rat primary antibodies with green and red DyLight® fluorescent dyes and a normal blocking serum. With the kit, one protocol replaces several and reduces preparation time – in some cases by as much as a day or more.

“These two reagents are commonly used together,” explains Harjit Kullar, vice president of marketing for Maravai LifeSciences.

“Using two stains sequentially requires a tedious, time-consuming protocol and complex workflow. The VectaFluor Duet combines the double staining into one protocol, providing time and cost savings.”

In the kit, Vector Laboratories’ affinity-purified, cross-adsorbed secondary antibodies are conjugated to DyLight dyes in a process that ensures maximum labeling without compromising antibody affinity or specificity.

The red and green DyLight anti-mouse/anti-rabbit antibodies are combined into a robust, stable cocktail that yields sensitive and consistent dual staining

VectaFluor Duet Immunofluorescence Double Labeling Kit, DyLight 488 Anti-Rabbit/DyLight 594 Anti-Mouse

Find out more >

Find out more about VectaFluor Duet

View Brochure >

Contact us for a quote

Contact Us >



Request a Quote

Request Quote

Recent Posts

2027 Abacus dx Emerging Investigators Grant

COMING SOON Grant in Research Funding Empowering the Next Generation of Scientific Leaders Stay tuned for the 2027 Abacus dx Emerging Investigators Grant. More information…

Read full article

Developing Diagnostic Kits for Ovarian Cancer

In Australia, ovarian cancer is the deadliest reproductive cancer. The average five‑year survival rate sits at around 49%, compared with about 92% for breast cancer,…

Read full article

Merck FemtoQuest™

Gain your desired immunoassay sensitivity with the ultrasensitive FemtoQuest™ system Measure down to femtogram/mL levels Improved precision and robust data Perform dual-plex and single analyte…

Read full article